Company: PETVW
Filing Date: 2025-07-10
Form Type: 10-K
Source: 0001641172-25-018617
Chunk: 41

Company: PetVivo Holdings, Inc.
Filing Date: 2025-07-10
Form: 10-K
Item: Item 1
Chunk 41
---
 initial public offering of common stock

On
August 13, 2021, we completed our Public Offering pursuant to which we issued and sold an aggregate of 2,500,000 units at the public
offering price of $4.50 per unit. Each unit consisted of one share of our common stock and one warrant to purchase one share of our common
stock at an exercise price of $5.625 per share. The shares of common stock and warrants were transferable separately immediately upon
issuance. At the closing of the Public Offering, the underwriter exercised its over-allotment option to purchase an additional 375,000
warrants for an aggregate purchase price of $3,850.

The
offer and sale of all of the units in our Public Offering were registered under the Securities Act pursuant to a registration statement
on Form S-1, as amended (File No. 333-249452), which was declared effective by the SEC on August 10, 2021 (“Registration Statement”).
ThinkEquity, a division of Fordham Financial Management, Inc. acted as the sole book-running manager for the Public Offering. In connection
with the Public Offering, the Company’s common stock and warrants were registered under Section 12(b) of the Exchange Act and began
trading on The Nasdaq Capital Market, LLC under the symbols “PETV” and “PETVW,” respectively.

27

We
received aggregate gross proceeds from our Public Offering of $11,253,850 (inclusive of the underwriter’s exercise of its overallotment
option to purchase warrants). After deducing underwriting discounts and commissions and other offering expenses, we received net proceeds
of approximately $9,781,000 from the Public Offering.

ITEM
6. RESERVED

Not
applicable.

ITEM
7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

The
following discussion of our financial condition and results of operations should be read in conjunction with our financial statements
and related notes that appear elsewhere in this prospectus. In addition to historical consolidated financial information, the following
discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially
from those discussed in the forward-looking statements. Factors that could cause or contribute to those differences include those discussed
below and elsewhere in this prospectus, particularly in “RISK FACTORS.” We caution the reader not to place undue reliance
on these forward-looking statements